Literature DB >> 33692947

Mitochondria's Role in the Maintenance of Cancer Stem Cells in Glioblastoma.

Yasaman Iranmanesh1, Biao Jiang2, Okoye C Favour1, Zhangqi Dou3, Jiawei Wu3, Jinfan Li4, Chongran Sun3.   

Abstract

Glioblastoma (GBM), one of the deadliest primary brain malignancies, is characterized by a high recurrence rate due to its limited response to existing therapeutic strategies such as chemotherapy, radiation therapy, and surgery. Several mechanisms and pathways have been identified to be responsible for GBM therapeutic resistance. Glioblastoma stem cells (GSCs) are known culprits of GBM resistance to therapy. GSCs are characterized by their unique self-renewal, differentiating capacity, and proliferative potential. They form a heterogeneous population of cancer stem cells within the tumor and are further divided into different subpopulations. Their distinct molecular, genetic, dynamic, and metabolic features distinguish them from neural stem cells (NSCs) and differentiated GBM cells. Novel therapeutic strategies targeting GSCs could effectively reduce the tumor-initiating potential, hence, a thorough understanding of mechanisms involved in maintaining GSCs' stemness cannot be overemphasized. The mitochondrion, a regulator of cellular physiological processes such as autophagy, cellular respiration, reactive oxygen species (ROS) generation, apoptosis, DNA repair, and cell cycle control, has been implicated in various malignancies (for instance, breast, lung, and prostate cancer). Besides, the role of mitochondria in GBM has been extensively studied. For example, when stressors, such as irradiation and hypoxia are present, GSCs utilize specific cytoprotective mechanisms like the activation of mitochondrial stress pathways to survive the harsh environment. Proliferating GBM cells exhibit increased cytoplasmic glycolysis in comparison to terminally differentiated GBM cells and quiescent GSCs that rely more on oxidative phosphorylation (OXPHOS). Furthermore, the Warburg effect, which is characterized by increased tumor cell glycolysis and decreased mitochondrial metabolism in the presence of oxygen, has been observed in GBM. Herein, we highlight the importance of mitochondria in the maintenance of GSCs.
Copyright © 2021 Iranmanesh, Jiang, Favour, Dou, Wu, Li and Sun.

Entities:  

Keywords:  GSC; glioblastoma; metabolism; mitochondria; quiescence; stem cell; stemness

Year:  2021        PMID: 33692947      PMCID: PMC7937970          DOI: 10.3389/fonc.2021.582694

Source DB:  PubMed          Journal:  Front Oncol        ISSN: 2234-943X            Impact factor:   6.244


  6 in total

Review 1.  The Interplay of Microtubules with Mitochondria-ER Contact Sites (MERCs) in Glioblastoma.

Authors:  Francesca Grespi; Caterina Vianello; Stefano Cagnin; Marta Giacomello; Agnese De Mario
Journal:  Biomolecules       Date:  2022-04-12

Review 2.  Bioengineered Models to Study Microenvironmental Regulation of Glioblastoma Metabolism.

Authors:  Joseph Chen; Hyunchul Lee; Philipp Schmitt; Caleb J Choy; Donald M Miller; Brian J Williams; Elaine L Bearer; Hermann B Frieboes
Journal:  J Neuropathol Exp Neurol       Date:  2021-09-15       Impact factor: 3.148

3.  The polarity protein Par3 coordinates positively self-renewal and negatively invasiveness in glioblastoma.

Authors:  Mahsa Shahidi Dadras; Laia Caja; Artur Mezheyeuski; Sijia Liu; Caroline Gélabert; Maria Catalina Gomez-Puerto; Radiosa Gallini; Carl-Johan Rubin; Peter Ten Dijke; Carl-Henrik Heldin; Aristidis Moustakas
Journal:  Cell Death Dis       Date:  2021-10-12       Impact factor: 8.469

Review 4.  Extracellular citrate and metabolic adaptations of cancer cells.

Authors:  E Kenneth Parkinson; Jerzy Adamski; Grit Zahn; Andreas Gaumann; Fabian Flores-Borja; Christine Ziegler; Maria E Mycielska
Journal:  Cancer Metastasis Rev       Date:  2021-12-21       Impact factor: 9.264

5.  Mitochondrial dysfunction and impaired growth of glioblastoma cell lines caused by antimicrobial agents inducing ferroptosis under glucose starvation.

Authors:  Kenji Miki; Mikako Yagi; Koji Yoshimoto; Dongchon Kang; Takeshi Uchiumi
Journal:  Oncogenesis       Date:  2022-10-04       Impact factor: 6.524

Review 6.  Mitochondrial DNA Alterations in Glioblastoma (GBM).

Authors:  Mariceli Baia Leão Barros; Danilo do Rosário Pinheiro; Bárbara do Nascimento Borges
Journal:  Int J Mol Sci       Date:  2021-05-29       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.